EBITDA SEK -2.9m vs. ABGSCe -1.3m Circular Energy sales at SEK 37.
No material updates in the Q1 report NEX-20 Ph 1 study completed by June '23e Live commentary today ...
Suominen reported weaker than expected sales and EBITDA, with costs peaking but not giving as much t...
Q-linea is in a transition period after the break with Thermo Fisher and in Q1 there is no reported ...
Q1 key items are largely in line with expectations Expect limited total cons '23e adj.
Proforma org. growth of 20% vs. ABGSCe 18% Focus on operating excellence going forward We expect con...
Redeye comments on Carasent's Q1 2023 report, showing a growth rate of 34% y/y and 16% organically y...
Redeye expects to increase its 2023 forecast following a solid estimate beat from I-Tech during the ...
Redeye comments on Nanexa’s Q1 report and notes important key activities carried out in the quarter.
Redeye believes that Sdiptech’s Q1 report was stronger than our expectations, with both segments exc...
Redeye comments its key takeaways from Xspray’s Q1 2023 report released this morning.
Redeye thinks Sivers delivered a good report, beating Redeye's estimates on topline by 7% and also b...
Redeye comments on Coala Life’s Q1’23 report, in which we note strong growth, a fast ramp-up in acti...
Redeye will likely slightly lower its forecast and Base Case following the Q1 report.
Redeye sees an unrecognized business with stable sales development, ongoing geographical expansion, ...
EBIT SEK 40m, +3% vs.ABGSCe, -3% vs. cons. Continues with margin improvements and high FCF conversio...
Price adjustments and better supply chain lift gross margin EBIT up 15% q-o-q is a good sign Gross m...
Sales +9% and adj. EBITA +58% vs. ABGSCe Margin expansion in both segments: Inission 8.
Taaleri's Q1 was underpinned by the strong performance of Garantia, but higher-than-expected costs w...
Q1 revenues were 3% below Refinitiv consensus and clean EBIT was 7% below.
